Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.17
$0.087.34%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 2.43% | 2.43% |
| Total Depreciation and Amortization | -- | -- | -- | 12.30% | 12.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | 116.45% | 116.45% |
| Total Other Non-Cash Items | -- | -- | -- | 127.14% | 127.14% |
| Change in Net Operating Assets | -- | -- | -- | -33.19% | -33.19% |
| Cash from Operations | -- | -- | -- | 27.42% | 27.42% |
| Capital Expenditure | -- | -- | -- | 45.73% | 45.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -53.22% | -53.22% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -421.41% | -421.41% |
| Cash from Investing | -- | -- | -- | -9.37% | -9.37% |
| Total Debt Issued | -- | -- | -- | -44.84% | -44.84% |
| Total Debt Repaid | -- | -- | -- | 37.88% | 37.88% |
| Issuance of Common Stock | -- | -- | -- | 288.02% | 294.87% |
| Repurchase of Common Stock | -- | -- | -- | -111.94% | -111.94% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -49.60% | -49.60% |
| Other Financing Activities | -- | -- | -- | 13.21% | 9.65% |
| Cash from Financing | -- | -- | -- | -71.11% | -71.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 137.96% | 137.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -14.92% | -14.92% |